These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 34321401)

  • 21. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.
    Singh AK; Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(4):283-287. PubMed ID: 32283499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney.
    Jiang X; Eales JM; Scannali D; Nazgiewicz A; Prestes P; Maier M; Denniff M; Xu X; Saluja S; Cano-Gamez E; Wystrychowski W; Szulinska M; Antczak A; Byars S; Skrypnik D; Glyda M; Król R; Zywiec J; Zukowska-Szczechowska E; Burrell LM; Woolf AS; Greenstein A; Bogdanski P; Keavney B; Morris AP; Heagerty A; Williams B; Harrap SB; Trynka G; Samani NJ; Guzik TJ; Charchar FJ; Tomaszewski M
    Eur Heart J; 2020 Dec; 41(48):4580-4588. PubMed ID: 33206176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
    Son M; Seo J; Yang S
    Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association of hypertension and antihypertensive agents and the severity of COVID-19 pneumonia. A monocentric French prospective study].
    Georges JL; Cochet H; Roger G; Ben Jemaa H; Soltani J; Azowa JB; Mamou R; Gilles F; Saba J; Prevot A; Pasqualini M; Monguillon V; De Tournemire M; Bertrand A; Koukabi-Fradelizi M; Beressi JP; Livarek B
    Ann Cardiol Angeiol (Paris); 2020 Nov; 69(5):247-254. PubMed ID: 33039120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection.
    Tsampasian V; Corballis N; Vassiliou VS
    Curr Hypertens Rep; 2022 Oct; 24(10):425-433. PubMed ID: 35716247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19.
    Salah HM; Mehta JL
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):114-118. PubMed ID: 33078623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
    Beyerstedt S; Casaro EB; Rangel ÉB
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review and Meta-Analysis.
    Chan CK; Huang YS; Liao HW; Tsai IJ; Sun CY; Pan HC; Chueh JS; Wang JT; Wu VC; Chu TS;
    Hypertension; 2020 Nov; 76(5):1563-1571. PubMed ID: 32869673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
    Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
    JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).
    Cadegiani FA; Goren A; Wambier CG
    Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019.
    Sanchis-Gomar F; Lavie CJ; Perez-Quilis C; Henry BM; Lippi G
    Mayo Clin Proc; 2020 Jun; 95(6):1222-1230. PubMed ID: 32376099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
    Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z
    Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of renin-angiotensin-aldosterone system inhibitors on disease severity and mortality in patients with COVID-19: A meta-analysis.
    Zhang G; Wu Y; Xu R; Du X
    J Med Virol; 2021 Apr; 93(4):2287-2300. PubMed ID: 33231299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.
    Vázquez-Cornejo E
    Bol Med Hosp Infant Mex; 2020; 77(5):274-281. PubMed ID: 33064690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
    Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
    J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections.
    Ferrara F; Vitiello A
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1589-1593. PubMed ID: 34151392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.
    Sattar Y; Mukuntharaj P; Zghouzi M; Suleiman AM; Attique H; Ullah W; Sana MK; Zaher N; Mehmood M; Doshi RP; Panchal A; Mir T; Nadeem M; Ali OE; Mohamed M; Bagur R; Elgendy IY; Mamas MA; Alraies MC
    High Blood Press Cardiovasc Prev; 2021 Jul; 28(4):405-416. PubMed ID: 34181203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension.
    Meng X; Liu Y; Wei C; Zhang K; Zhang Y; Zhong M; Zhang C; Zhang Y
    Sci China Life Sci; 2021 May; 64(5):836-839. PubMed ID: 32975722
    [No Abstract]   [Full Text] [Related]  

  • 40. Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.
    Sandhu AT; Kohsaka S; Lin S; Woo CY; Goldstein MK; Heidenreich PA
    Am Heart J; 2021 Oct; 240():46-57. PubMed ID: 34126079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.